October 2, 2009 – Resverlogix Corp. said this week results from the company's second clinical trial for the drug RVX-208 showed it increases the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL).

October 2, 2009 – CardioComm Solutions Inc. said yesterday it added the company’s wireless ECG management system to its suite of GEMS (Global ECG Management System) products. GEMS Air builds on the GEMS platform and incorporates software capable of continuously receiving and managing recordings of the heart’s activity over a wireless network instead of a land-line telephone network.

A broad array of contrast and injection management products for diagnostic imaging in radiology are provided with the EmpowerCTA Contrast Injector by ACIST Medical Systems Inc. The system is integrated with the IRiSCT Data Management System, provides a new level of integrative, informative and intuitive solutions to radiology suites around the world.

October 1, 2009 - While we wait for the definition of "meaningful use," Dr. David Blumenthal, M.D., M.P.P., National Coordinator for Health Information Technology, recommends physicians become "as familiar as possible with the discussion of meaningful use criteria to date."

October 1, 2009 – Flexible Stenting Solutions Inc. (FSS) said this week it received conditional investigational device exemption (IDE) approval from the FDA for its FlexStent Femoropopliteal Self-Expanding Stent System so it can begin its U.S. clinical trial at up to 10 clinical sites and with 50 patients.

October 1, 2009 – Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming and self-anchoring technology for transcatheter mitral valve implantation (TMVI) system, announced successful results at TCT 2009 from its acute in vivo study.

October 1, 2009 – The six-month clinical outcome of Sahajanand Medical Technologies Supralimus Sirolimus-Eluting Stent with a bioabsorbable polymer was highlighted by the company at TCT 2009.

October 1, 2009 – Invatec recently launched the REEF HP PTA Balloon Catheter at CIRSE 2009, which the company said is ideal for use in all peripheral high-pressure dilatation procedures.

October 1, 2009 – Spectranetics Corp. yesterday said it filed a 510(k) application with the U.S. Food and Drug Administration seeking clearance for the treatment of in-stent restenosis (ISR) in the legs with its commercially available peripheral atherectomy laser products.

September 30, 2009 – PLC Systems Inc. demonstrated its RenalGuard System to help prevent contrast-induced nephropathy (CIN) and presented data from its MYTHOS Clinical Trial at the Transcatheter Cardiovascular Therapeutics (TCT) 2009 symposium last week in San Francisco.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now